Pharmaceutical companies have taken to paying off generic drug manufacturers to delay them producing lower cost equivalents to name brand drugs at the expiration of patents. Is this the way the market is supposed to work? It is certainly not in the interests of the consumer. Sen. Leahy (D - VT) wants to put a stop to it but I am sure that this will raise a chorus of complaint from the free marketeers of the right at this unnecessary government intrusion into the sanctity of the marketplace.
No comments:
Post a Comment